Cdk5 interacts with Hif-1α in neurons: a new hypoxic signalling mechanism?

Xanthi Antoniou1, Max Gassmann, Omolara O Ogunshola

  • 1Institute of Veterinary Physiology, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland.

Brain Research
|October 28, 2010
PubMed

Insights

The cyclin-dependent kinase 5 (Cdk5)/p35 complex regulates neuronal survival during hypoxia. Cdk5 inhibition impairs hypoxia-inducible factor 1-alpha (Hif-1α) stabilization, leading to cell death, revealing a novel neuroprotective pathway.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Molecular Biology

Background:

  • The cyclin-dependent kinase 5 (Cdk5)/p35 complex is crucial for neuronal survival and implicated in neurodegenerative diseases.
  • Dysregulation of Cdk5 activity, often due to altered p35/p39 levels, is linked to conditions like Alzheimer's disease.
  • Hypoxia is a significant factor in the pathology of various neurological disorders, but its interaction with Cdk5 is not well understood.

Purpose of the Study:

  • To investigate the role of the Cdk5/p35 complex in the neuronal response to hypoxia.
  • To determine if Cdk5/p35 signaling influences hypoxia-inducible factor 1-alpha (Hif-1α) stabilization under oxygen deprivation.
  • To elucidate a novel signaling pathway involving Cdk5/p35 in neuronal survival during hypoxic conditions.

Main Methods:

  • Primary cortical neurons were subjected to hypoxic conditions.
  • Modulation of the p35/Cdk5 complex at transcriptional and protein levels was assessed.
  • Cdk5 activity and its correlation with Hif-1α stabilization were measured.
  • The effect of Cdk5 inhibition (using roscovitine) on Hif-1α accumulation and neuronal survival was evaluated.

Main Results:

  • Hypoxia was found to modulate the p35/Cdk5 complex in primary cortical neurons.
  • Increased Cdk5 activity during hypoxia correlated with Hif-1α stabilization, with evidence of direct interaction.
  • Inhibition of Cdk5 using roscovitine prevented Hif-1α accumulation and resulted in neuronal cell death.
  • The study identified a novel hypoxia-mediated signaling pathway involving Cdk5/p35 and Hif-1α.

Conclusions:

  • The Cdk5/p35 complex plays a significant role in modulating Hif-1α stabilization during oxygen deprivation.
  • This Cdk5/p35-Hif-1α pathway impacts neuronal survival under hypoxic stress.
  • The findings highlight the cytoskeleton's potential role in regulating Hif-1α and offer a new therapeutic target for neurological disorders involving hypoxia.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...